{"filing":{"accession_number":"0001627223-26-000021","cik":"0001627223","ticker":"CC","company_name":"Chemours Co","form":"8-K","filing_date":"2026-08-04","report_date":"2026-08-04","primary_document":"cc-20260804.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1627223/000162722326000021/cc-20260804.htm"},"events":[{"id":23675,"run_id":21410,"accession_number":"0001627223-26-000021","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"summary":"The Chemours Company issued a press release on August 4, 2026, disclosing its second quarter 2026 financial results, including net sales of $1.6 billion, net loss of $274 million ($1.81 per diluted share), and adjusted EBITDA of $247 million. The filing explicitly states \"The Chemours Company Reports Second Quarter Results\" and provides comprehensive quarterly financial metrics, segment performance, and forward guidance—the hallmark of an earnings release under Item 2.02.","company_name":"Chemours Co","ticker":"CC","filing_date":"2026-08-04","form":"8-K","submitted_at":null,"items":[{"id":23978,"accession_number":"0001627223-26-000021","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"The Chemours Company issued a press release on August 4, 2026, disclosing its second quarter 2026 financial results, including net sales of $1.6 billion, net loss of $274 million ($1.81 per diluted share), and adjusted EBITDA of $247 million. The filing explicitly states \"The Chemours Company Reports Second Quarter Results\" and provides comprehensive quarterly financial metrics, segment performance, and forward guidance—the hallmark of an earnings release under Item 2.02.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-05T00:22:44.811452+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":23978,"accession_number":"0001627223-26-000021","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"The Chemours Company issued a press release on August 4, 2026, disclosing its second quarter 2026 financial results, including net sales of $1.6 billion, net loss of $274 million ($1.81 per diluted share), and adjusted EBITDA of $247 million. The filing explicitly states \"The Chemours Company Reports Second Quarter Results\" and provides comprehensive quarterly financial metrics, segment performance, and forward guidance—the hallmark of an earnings release under Item 2.02.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-05T00:22:44.811452+00:00","company_name":"Chemours Co","ticker":"CC","filing_date":"2026-08-04"}]}